Download | < Back |
08 Apr 2024 | |
Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we hereby inform you that the Board of Directors of the Company at its Board Meeting held today, April 08, 2024, inter-alia, considered and approved the following: | |
View all announcements for Oxygenta Pharmaceutical Ltd | Source: BSE India |